These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34540201)

  • 1. Enhancement of pyocyanin production by subinhibitory concentration of royal jelly in
    Amly DA; Hajardhini P; Jonarta AL; Yulianto HDK; Susilowati H
    F1000Res; 2021; 10():14. PubMed ID: 34540201
    [No Abstract]   [Full Text] [Related]  

  • 2. Royal Jelly Inhibits
    Susilowati H; Murakami K; Yumoto H; Amoh T; Hirao K; Hirota K; Matsuo T; Miyake Y
    Biomed Res Int; 2017; 2017():3191752. PubMed ID: 29075644
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of daphnetin on biofilm formation and motility of
    Ye Z; Ye L; Li D; Lin S; Deng W; Zhang L; Liang J; Li J; Wei Q; Wang K
    Front Cell Infect Microbiol; 2022; 12():1033540. PubMed ID: 36467736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa
    Van Laar TA; Esani S; Birges TJ; Hazen B; Thomas JM; Rawat M
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669887
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction of pyocyanin synthesis and antibiotic resistance in Pseudomonas aeruginosa by low concentration ethanol.
    Jiang S; Deng Y; Long Z; Liu P; Hong J; Wei T; Zhang Y; Sun S; Zhuo S; Shang L
    FEMS Microbiol Lett; 2023 Jan; 370():. PubMed ID: 37451707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of virulence factor pyocyanin production in multidrug-resistant Pseudomonas aeruginosa.
    Fuse K; Fujimura S; Kikuchi T; Gomi K; Iida Y; Nukiwa T; Watanabe A
    J Infect Chemother; 2013 Feb; 19(1):82-8. PubMed ID: 22865331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyocyanin: production, applications, challenges and new insights.
    Jayaseelan S; Ramaswamy D; Dharmaraj S
    World J Microbiol Biotechnol; 2014 Apr; 30(4):1159-68. PubMed ID: 24214679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and biological characterization of pyocyanin from clinical and environmental Pseudomonas aeruginosa.
    Shouman H; Said HS; Kenawy HI; Hassan R
    Microb Cell Fact; 2023 Aug; 22(1):166. PubMed ID: 37644606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming microbial pigment into therapeutic revelation: extraction and characterization of pyocyanin from Pseudomonas aeruginosa and its therapeutic potential as an antibacterial and anticancer agent.
    Marey MA; Abozahra R; El-Nikhely NA; Kamal MF; Abdelhamid SM; El-Kholy MA
    Microb Cell Fact; 2024 Jun; 23(1):174. PubMed ID: 38867319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrochemical sensors for identifying pyocyanin production in clinical Pseudomonas aeruginosa isolates.
    Sismaet HJ; Pinto AJ; Goluch ED
    Biosens Bioelectron; 2017 Nov; 97():65-69. PubMed ID: 28570940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in toxin production of environmental Pseudomonas aeruginosa isolates exposed to sub-inhibitory concentrations of three common antibiotics.
    Mojsoska B; Ghoul M; Perron GG; Jenssen H; Alatraktchi FA
    PLoS One; 2021; 16(3):e0248014. PubMed ID: 33662048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilm Formation, Pyocyanin Production, and Antibiotic Resistance Profile of
    Chimi LY; Noubom M; Bisso BN; Singor Njateng GS; Dzoyem JP
    Int J Microbiol; 2024; 2024():1207536. PubMed ID: 38414729
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-thermal plasma causes
    Kašparová P; Vaňková E; Paldrychová M; Svobodová A; Hadravová R; Jarošová Kolouchová I; Masák J; Scholtz V
    Front Cell Infect Microbiol; 2022; 12():993029. PubMed ID: 36211963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of growth, biofilm and secreted virulence in opportunistic nosocomial Pseudomonas aeruginosa ATCC 25619 by glycyrrhetinic acid.
    Kannan S; Sathasivam G; Marudhamuthu M
    Microb Pathog; 2019 Jan; 126():332-342. PubMed ID: 30458255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence attributes in Brazilian clinical isolates of Pseudomonas aeruginosa.
    Silva LV; Galdino AC; Nunes AP; dos Santos KR; Moreira BM; Cacci LC; Sodré CL; Ziccardi M; Branquinha MH; Santos AL
    Int J Med Microbiol; 2014 Nov; 304(8):990-1000. PubMed ID: 25127423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High pyocyanin production and non-motility of Pseudomonas aeruginosa isolates are correlated with septic shock or death in bacteremic patients.
    Gupte A; Jyot J; Ravi M; Ramphal R
    PLoS One; 2021; 16(6):e0253259. PubMed ID: 34115807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crataeva nurvala nanoparticles inhibit virulence factors and biofilm formation in clinical isolates of Pseudomonas aeruginosa.
    Ali SG; Ansari MA; Khan HM; Jalal M; Mahdi AA; Cameotra SS
    J Basic Microbiol; 2017 Mar; 57(3):193-203. PubMed ID: 27874198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyocyanin promotes extracellular DNA release in Pseudomonas aeruginosa.
    Das T; Manefield M
    PLoS One; 2012; 7(10):e46718. PubMed ID: 23056420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual activity of pyocyanin from Pseudomonas aeruginosa--antibiotic against phytopathogen and signal molecule for biofilm development by rhizobia.
    Khare E; Arora NK
    Can J Microbiol; 2011 Sep; 57(9):708-13. PubMed ID: 21851321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endolichenic fungus, Aspergillus quandricinctus of Usnea longissima inhibits quorum sensing and biofilm formation of Pseudomonas aeruginosa PAO1.
    Prateeksha ; Bajpai R; Yusuf MA; Upreti DK; Gupta VK; Singh BN
    Microb Pathog; 2020 Mar; 140():103933. PubMed ID: 31862392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.